Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Clinical trial NCT00575016 · TERMINATED

Trial details

NCT number: NCT00575016
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2007-12-01
Primary completion: 2010-02-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.